AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+6.93%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.72B
AUM Growth
+$3.72B
(-6.4%)
Cap. Flow
-$740M
Cap. Flow
% of AUM
-19.91%
Top 10 Holdings %
Top 10 Hldgs %
33.01%
Holding
258
New
61
Increased
36
Reduced
52
Closed
65
Top Buys
| 1 |
Amazon
AMZN
|
$77.8M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$72M |
| 3 |
Biogen
BIIB
|
$48.7M |
| 4 |
PARA
Paramount Global Class B
PARA
|
$45.6M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$44.8M |
Top Sells
| 1 |
Madrigal Pharmaceuticals
MDGL
|
$298M |
| 2 |
Ross Stores
ROST
|
$114M |
| 3 |
Incyte
INCY
|
$76.6M |
| 4 |
Five Below
FIVE
|
$76.2M |
| 5 |
lululemon athletica
LULU
|
$74.2M |
Sector Composition
| 1 | Healthcare | 70.93% |
| 2 | Consumer Staples | 8.88% |
| 3 | Technology | 6.85% |
| 4 | Consumer Discretionary | 6.74% |
| 5 | Communication Services | 4.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Intuitive Surgical
ISRG
$158B
| $53.1M | 0.93% |
200,000
-28,000
| -12% | -$7.43M |
|
27
Medtronic
MDT
$118B
| $52.2M | 0.91% |
672,000
-52,000
| -7% | -$4.04M |
|
28
CVS Health
CVS
$93B
| $44.4M | 0.77% |
+476,000
| New | +$44.4M |
|
29
Vertex Pharmaceuticals
VRTX
$102B
| $42.7M | 0.75% |
148,000
-2,000
| -1% | -$578K |
|
30
Novo Nordisk
NVO
$252B
| $42.2M | 0.74% |
+312,000
| New | +$42.2M |
|
31
CRISPR Therapeutics
CRSP
$4.82B
| $42.1M | 0.73% |
1,036,000
+112,000
| +12% | +$4.55M |
|
32
MacroGenics
MGNX
$121M
| $40.9M | 0.71% |
6,092,000
-36,000
| -0.6% | -$242K |
|
|
ISEE
33
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $38.4M | 0.67% |
1,792,000
+428,000
| +31% | +$9.16M |
|
34
Biohaven
BHVN
$1.71B
| $37.8M | 0.66% |
2,724,000
+1,292,000
| +90% | +$17.5M |
|
|
EVBG
35
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $31.7M | 0.55% |
1,072,000
+316,000
| +42% | +$9.35M |
|
36
Alibaba
BABA
$325B
| $31.4M | 0.55% |
356,000
+32,000
| +10% | +$2.82M |
|
37
AB InBev
BUD
$116B
| $29.9M | 0.52% |
498,000
-650,000
| -57% | -$39M |
|
38
Post Holdings
POST
$6.03B
| $28.6M | 0.5% |
317,000
-7,000
| -2% | -$632K |
|
39
Kraft Heinz
KHC
$31.9B
| $28.1M | 0.49% |
690,000
-960,000
| -58% | -$39.1M |
|
40
Energizer
ENR
$1.94B
| $27.6M | 0.48% |
824,000
-728,000
| -47% | -$24.4M |
|
41
Dentsply Sirona
XRAY
$2.77B
| $26.6M | 0.46% |
+836,000
| New | +$26.6M |
|
42
Adobe
ADBE
$148B
| $26.2M | 0.46% |
78,000
-106,000
| -58% | -$35.7M |
|
43
Rigel Pharmaceuticals
RIGL
$710M
| $25.4M | 0.44% |
16,956,000
+13,503,126
| +391% | +$20.3M |
|
44
Clorox
CLX
$15B
| $24.3M | 0.42% |
+173,000
| New | +$24.3M |
|
45
DocuSign
DOCU
$15.3B
| $23.1M | 0.4% |
+416,000
| New | +$23.1M |
|
46
Toast
TOST
$24.7B
| $22.6M | 0.4% |
1,256,000
+92,000
| +8% | +$1.66M |
|
47
Aurinia Pharmaceuticals
AUPH
$1.58B
| $21.6M | 0.38% |
5,000,000
+4,276,000
| +591% | +$18.5M |
|
48
UnitedHealth
UNH
$279B
| $21.2M | 0.37% |
40,000
+16,000
| +67% | +$8.48M |
|
49
Voyager Therapeutics
VYGR
$204M
| $20.7M | 0.36% |
3,396,000
| – | – |
|
|
50
Ross Stores
ROST
$49.3B
| $20.3M | 0.35% |
175,000
-983,117
| -85% | -$114M |
|